Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT(1A) Receptor Agonist

It has been suggested that drugs combining activities of selective serotonin reuptake inhibitor and 5-HT(1A) receptor agonist may form a novel strategy for higher therapeutic efficacy of antidepressant. The present study aimed to examine the pharmacology of YL-0919, a novel synthetic compound with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hong-xia, Jin, Zeng-liang, Zhang, Li-ming, Xue, Rui, Xu, Xiao-dan, Zhao, Nan, Qiu, Zhi-kun, Wang, Xian-wang, Zhang, You-zhi, Yang, Ri-fang, Li, Yun-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867442/
https://www.ncbi.nlm.nih.gov/pubmed/24367588
http://dx.doi.org/10.1371/journal.pone.0083271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867442/
https://www.ncbi.nlm.nih.gov/pubmed/24367588
http://dx.doi.org/10.1371/journal.pone.0083271

Ejemplares similares